These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31267923)

  • 21. Appropriate liver resection type for patients with the American joint committee on cancer classification T1 and T2 hepatocellular carcinoma.
    Hsieh CB; Chung KP; Chu CM; Yu JC; Hsieh HF; Chu HC; Yu CY; Chen TW
    Eur J Surg Oncol; 2011 Jun; 37(6):497-504. PubMed ID: 21450438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-treatment alphafeto protein in hepatocellular carcinoma with non-viral aetiology - a prospective study.
    Chaminda SR; Suchintha T; Anuk NM; Supun DA; Bhagya GM; Habarakada LCA; Janaka SH
    BMC Gastroenterol; 2017 Dec; 17(1):142. PubMed ID: 29207969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative investigation and indication for operation in hepatocellular carcinoma.
    Riordan SM; Williams R
    J Hepatobiliary Pancreat Surg; 1998; 5(1):1-6. PubMed ID: 9683746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevation of alpha-fetoprotein level without evidence of recurrence after hepatectomy for hepatocellular carcinoma.
    Ezaki T; Yukaya H; Ogawa Y; Chang YC; Nagasue N
    Cancer; 1988 May; 61(9):1880-3. PubMed ID: 2451558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.
    Leerapun A; Suravarapu SV; Bida JP; Clark RJ; Sanders EL; Mettler TA; Stadheim LM; Aderca I; Moser CD; Nagorney DM; LaRusso NF; de Groen PC; Menon KV; Lazaridis KN; Gores GJ; Charlton MR; Roberts RO; Therneau TM; Katzmann JA; Roberts LR
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):394-402; quiz 267. PubMed ID: 17368240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.
    Ha SY; Kim JH; Yang JW; Kim J; Kim B; Park CK
    Cancer Res Treat; 2016 Jul; 48(3):1065-73. PubMed ID: 26511806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal.
    Blank S; Wang Q; Fiel MI; Luan W; Kim KW; Kadri H; Mandeli J; Hiotis SP
    Ann Surg Oncol; 2014 Mar; 21(3):986-94. PubMed ID: 24232510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of a new inflammation-based scoring system for prognostication of patients with hepatocellular carcinoma after hepatectomy.
    Mori S; Kita J; Kato M; Shimoda M; Kubota K
    Am J Surg; 2015 Jan; 209(1):187-93. PubMed ID: 24950991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. History and recent progress in evaluation of the fucosylated alpha-fetoprotein fraction.
    Aoyagi Y; Tamura Y; Suda T
    J Gastroenterol Hepatol; 2011 Apr; 26(4):615-6. PubMed ID: 21418297
    [No Abstract]   [Full Text] [Related]  

  • 31. Relevance of Pre-Transplant α-fetoprotein Dynamics in Liver Transplantation for Hepatocellular Cancer.
    Grąt M; Krasnodębski M; Patkowski W; Wronka KM; Masior Ł; Stypułkowski J; Grąt K; Krawczyk M
    Ann Transplant; 2016 Feb; 21():115-24. PubMed ID: 26887339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spontaneous drastic reduction of alpha-fetoprotein in hepatocellular carcinoma.
    Phadke AY; Desai HG
    Indian J Gastroenterol; 1996 Jul; 15(3):111. PubMed ID: 8840646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-Term Outcome After Resection of Huge Hepatocellular Carcinoma ≥ 10 cm: Single-Institution Experience with 471 Patients.
    Hwang S; Lee YJ; Kim KH; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Lee SG
    World J Surg; 2015 Oct; 39(10):2519-28. PubMed ID: 26126423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha fetoprotein changes predict hepatocellular carcinoma survival beyond the Milan criteria after hepatectomy.
    Shen JY; Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ
    J Surg Res; 2017 Mar; 209():102-111. PubMed ID: 28032546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological risk factors for recurrence within one year after initial hepatectomy for hepatocellular carcinoma.
    Hayashi M; Shimizu T; Hirokawa F; Inoue Y; Komeda K; Asakuma M; Miyamoto Y; Takeshita A; Shibayama Y; Tanigawa N
    Am Surg; 2011 May; 77(5):572-8. PubMed ID: 21679590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha-fetoprotein: a controversial prognostic biomarker for small hepatocellular carcinoma.
    Asrih M; Lenglet S; Mach F; Montecucco F
    World J Gastroenterol; 2013 Jan; 19(3):328-30. PubMed ID: 23372353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and prognostic significance of urinary trypsin inhibitor in patients with hepatocellular carcinoma after hepatectomy.
    Kikuchi I; Uchinami H; Nanjo H; Hashimoto M; Nakajima A; Kume M; Mencin A; Yamamoto Y
    Ann Surg Oncol; 2009 Oct; 16(10):2805-17. PubMed ID: 19636634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison between alpha-fetoprotein and p53 antibodies in the diagnosis of hepatocellular carcinoma.
    Edis C; Kähler C; Klotz W; Herold M; Feichtinger H; Königsreiner A; Margreiter R; Jaschke W; Vogel W
    Transplant Proc; 1998 May; 30(3):780-1. PubMed ID: 9595095
    [No Abstract]   [Full Text] [Related]  

  • 40. Postoperative serum osteopontin level is a novel monitor for treatment response and tumor recurrence after resection of hepatitis B-related hepatocellular carcinoma.
    Zhou C; Zhou HJ; Zhang XF; Lou LL; Ye QH; Zheng Y; Wang J; Zhu HT; Dong QZ; Jia HL; Zhu WW; Guo L; Zhao Y; Gao DM; Qin LX
    Ann Surg Oncol; 2013 Mar; 20(3):929-37. PubMed ID: 23203407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.